Bio-Rad Laboratories | BIO - Assets


Bio-Rad Laboratories reported $9.7B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
Agilent USD 12.73B 501M Sep/2025
Becton, Dickinson and Co. USD 55.32B 423M Sep/2025
Bio Techne USD 2.53B 31.72M Sep/2025
Bio-Rad Laboratories USD 9.7B 517.7M Sep/2025
Bruker USD 6.43B 95.1M Sep/2025
Charles River Laboratories USD 7.51B 46.73M Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Exact Sciences USD 5.9B 102.64M Sep/2025
General Electric Aerospace USD 130.17B 1.93B Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
Illumina USD 6.18B 90M Sep/2025
IQVIA Holdings USD 28.73B 95M Sep/2025
Laboratory Of America USD 18.26B 201.7M Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Mettler Toledo International USD 3.52B 121M Sep/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Quest Diagnostics USD 16.2B 228M Sep/2025
Repligen USD 2.92B 22.08M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Siemens EUR 166.2B 3.75B Sep/2025
Standard Biotools USD 539.64M 17.32M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Tosoh JPY 1.3T 9.78B Sep/2025
Waters USD 4.86B 144.49M Sep/2025